SENP1 Antibodies

Santa Cruz Biotechnology provides a broad selection of SENP1 monoclonal antibodies for investigating SUMO-specific protease 1 (SENP1) in cellular processes. SENP1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SENP1 is essential for regulating protein SUMOylation, a post-translational modification that influences protein stability, localization, and activity. Through modulation of SUMOylation status, SENP1 significantly impacts various biological processes, including cell cycle regulation, stress response, and transcriptional control. Research has shown that SENP1 activity is closely linked to the development and progression of cancer and neurodegenerative disorders. Investigating SENP1 function continues to reveal new insights into cellular regulation and disease mechanisms. Understanding SENP1's role in SUMOylation pathways opens new possibilities for therapeutic interventions. Exploring SENP1 mechanisms provides valuable information about cellular homeostasis and stress responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SENP1's role in health and disease.